On behalf of the Scientific Program Planning Committee and PDA Europe, we are proud to present the 11th Parenteral Packaging Conference, to take on 27-28 April 2021!
This conference has become highly regarded for its content and quality, and this year’s edition will continue the series of exceptional presentations and discussions. Industry leaders and technical experts from pharma and supplier companies along with regulators will cover many aspects of the drug -package interface.
Primary packaging of a parenteral pharmaceutical drug product should be designed, processed and manufactured, to ensure efficacy and safety of the patients. In particular, biopharmaceuticals require special considerations for aseptic processing and packaging.
Developments in packaging materials such as innovations in glass and polymer, and their characteristics regarding interactions with the drug product formulation and end-user preferences will be discussed. Case studies of the implementation of new guidelines, for example Annex 1 of the European GMP Guideline and USP 800 along with some of the latest developments in packaging materials & components and the role of Container Closure Integrity (CCI) in product-package development, assembly and processing will be presented. Low temperature storage of biopharmaceuticals for cell and gene therapy poses new challenges to packaging materials. Two way interactions of drug product/substance and container closures and their impact on drug stability, container functionality and device performance will be discussed.
The conference program is intended to initiate and support discussion and professional exchange through a diversity of scientific presentations, workshops, interest group meetings, training courses, joint dinners and networking events.
We look forward to you joining us in which we hope to be a face-to-face meeting once again!
Roman Mathaes, PhD, LONZA
Galen Shi, PhD, Eli Lilly & Company